Planning safer electron FLASH radiation treatments
Official title: Treatment Planning System for Electron FLASH radiation therapy
Funded at University of Missouri-Columbia · NIH-11319868 · Data updated 2026-11-12
This project builds computer tools to help doctors plan electron FLASH radiation that may better protect healthy tissue for people needing high‑dose radiotherapy.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Missouri-Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project start | February 6, 2024 |
| Project end | July 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $219,624 |
| NIH project number | 5R21CA277420-03 |
| Project ID | NIH-11319868 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal future candidates would be patients with deep or radioresistant tumors who might qualify for clinical FLASH radiation trials at specialized centers.
✕Less likely to help
People whose care does not involve high‑dose radiotherapy, or who are ineligible for radiation, are unlikely to benefit directly from this planning work.
What this research studies
From a patient perspective, researchers are creating and testing a treatment‑planning system that models how ultra‑high dose rate electron FLASH radiation deposits dose in larger, deeper bodies. They will use advanced simulations, imaging data, and comparisons with animal models to understand and reduce dose inhomogeneities. The team plans to adapt the planning tools for use at clinical radiation centers so plans for humans and large animals can be generated more reliably. Their work aims to make FLASH treatments safer and more predictable before wider human testing.
Why it matters
Potential benefit: If successful, this could let doctors give very high‑dose radiation while reducing harm to normal organs, potentially enabling treatment of tumors that are otherwise too risky to irradiate.
How similar studies have gone: Early small‑animal studies have reported reduced normal tissue damage with FLASH and a few large‑animal or early human efforts have started, but clinical benefit is still not proven.
Where this research is happening
-
University of Missouri-Columbia
Columbia, United States Active
Researchers
- Principal investigator: Zhang, Rongxiao — University of Missouri-Columbia
- Study coordinator: Zhang, Rongxiao
Related research
Other NIH-funded projects on the same topics.
-
Protecting small blood vessels from radiation by boosting mitochondrial health
It aims to prevent radiation-related damage to tiny blood vessels and reduce later thinking and memory problems in people who get radiation therapy by protecting cell mitochondria.
-
Proton SBRT for refractory ventricular tachycardia with real-time 3D/4D imaging
A patient-facing study exploring a proton-based, noninvasive radiation therapy to treat stubborn VT using advanced 3D and 4D imaging to target the heart safely.
-
Embedding symptom support in radiation therapy for prostate cancer
A multi-site study tests whether delivering mindfulness-based symptom support right inside radiation therapy is feasible and acceptable for men with prostate cancer.
-
Targeting SREBP2 to boost radiation therapy in HPV-negative head and neck cancer
This grant aims to see if blocking SREBP2 can make radiation therapy work better for people with HPV-negative Head and Neck Squamous Cell Carcinoma.
-
Genetic and Immune Factors in Squaring the Room: Sacituzumab plus Radiation for Bladder Cancer
A study aims to understand why combining sacituzumab with radiation helps some bladder cancer patients more than others, with the goal of making bladder-sparing therapy more effective.
-
CivaDerm: a new four-day skin cancer radiation bandage
A new four‑day radiation bandage for non-melanoma skin cancer aims to treat facial and other areas without multiple clinic visits or big scars.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.